Status:

COMPLETED

Safety and Feasibility of a Novel Device for Assessing Respiratory Function in Children

Lead Sponsor:

ResMed

Conditions:

Asthma in Children

Eligibility:

All Genders

3-18 years

Phase:

NA

Brief Summary

This is an early phase pilot study designed to test the safety and feasibility of using a novel, wireless, wearable device (Leo) for assessing respiratory parameters (lung volume, respiration rate, he...

Eligibility Criteria

Inclusion

  • Children aged ≥3 years old and ≤18 years old at time of consent
  • Children with a legal guardian able to sign consent for study participation
  • Children and caregivers able to read and understand English or Spanish
  • Investigator confirmation for diagnosis of clinically stable respiratory condition, such as clinically diagnosed asthma
  • Children who are able to follow instructions and complete oscillometry and tidal breathing tasks

Exclusion

  • \- Children \<3 and \>18 years of age
  • Adults (age ≥ 18 years)
  • Children with complex medical conditions which may hinder their ability to complete protocol assessments
  • Children who do not have a legal guardian to sign informed consent form
  • Children with an active skin condition involving the area on the chest wall where the Leo device will be attached. E.g. inflamed and/or infected eczema or other skin conditions involving the anterior chest wall at the time of recruitment
  • Child is determined not eligible by the assessment of the PI
  • Fever within the 4 weeks prior to enrollment
  • Children with any implanted medical devices, E.g. cardiac pacemaker
  • Children with any history of known allergic reaction to adhesives or hydrogels, as the ones used with the Leo device
  • Children who have taken a bronchodilator in the last 8-24 hours prior to study visit, depending on the type of medication.

Key Trial Info

Start Date :

July 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 21 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04873193

Start Date

July 1 2021

End Date

January 21 2022

Last Update

September 26 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Colorado Hospital

Aurora, Colorado, United States, 80045

Safety and Feasibility of a Novel Device for Assessing Respiratory Function in Children | DecenTrialz